S100B and central nervous system cancer: In recent years, great progress was obtained in the molecular pathology of neuro-tumors and a series of molecular markers have been found to be helpful in the clinical differential diagnosis and prognosis predicting of gliomas, among which Ki-67, vimentin, CD34 and S-100 are four vital biological behavior biomarkers [11–15].